Treatment for adults with moderate to severe psoriasis approved by FDA
A treatment for adults with moderate-to-severe plaque psoriasis who are candidates for systemic therapy or…
September 12, 2022 - 3 minutes
Skin disease
Lutris Pharma radiation trial brings positive results for breast cancer patients
Top line results from a clinical trial treating breast cancer patients with radiation dermatitis (RD)…
September 8, 2022 - 4 minutes
Psoriasis pustules disappear in over half of patients using Boehringer Ingelheim drug
More than half of patients treated for psoriasis with an intravenous injection showed no visible…
September 2, 2022 - 2 minutes
Ilya Pharma finalizes global patent coverage for modified lactic acid bacteria to treat wounds
Ilya Pharma, a Swedish clinical stage biopharma company focused on delivering local immunotherapies to patients,…
August 25, 2022 - 2 minutes
Treatment for patients with fragile skin disease accepted by FDA
The U.S. Food and Drug Administration (FDA) has accepted the filing of a biologic license…
August 19, 2022 - 3 minutes
Almirall launches new call to find innovative therapies for skin diseases
A new call for new therapies to treat skin diseases has been launched by global…
July 21, 2022 - 3 minutes
Krystal Biotech looks for FDA approval for dystrophic epidermolysis bullosa treatment
U.S. gene therapy company Krystal Biotech, Inc, has submitted a Biologics License Application (BLA) to…
June 23, 2022 - 3 minutes
